These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15978232)

  • 1. Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.
    Yang J; Te AE
    Curr Urol Rep; 2005 Jul; 6(4):290-5. PubMed ID: 15978232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome.
    Potts JM
    Curr Urol Rep; 2005 Jul; 6(4):313-7. PubMed ID: 15978236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saw palmetto for prostate disorders.
    Gordon AE; Shaughnessy AF
    Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
    Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
    Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.
    Carraro JC; Raynaud JP; Koch G; Chisholm GD; Di Silverio F; Teillac P; Da Silva FC; Cauquil J; Chopin DK; Hamdy FC; Hanus M; Hauri D; Kalinteris A; Marencak J; Perier A; Perrin P
    Prostate; 1996 Oct; 29(4):231-40; discussion 241-2. PubMed ID: 8876706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
    BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on the appropriateness of The Prostate publishing a trial comparing Permixon to finasteride without a placebo control group.
    Gillenwater JY
    Prostate; 1998 Nov; 37(3):194. PubMed ID: 9792137
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
    Sökeland J
    BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serenoa repens--the saw palmetto or dwarf palm].
    Swoboda H; Kopp B
    Wien Med Wochenschr; 1999; 149(8-10):235. PubMed ID: 10483689
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of saw palmetto fruit extract in the treatment of prostate diseases].
    Zhan XX; Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2015 Sep; 21(9):841-6. PubMed ID: 26552220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saw palmetto for benign prostatic hyperplasia.
    McKinney DE
    JAMA; 1999 May; 281(18):1699. PubMed ID: 10328068
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management.
    Luzzi GA
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):253-6. PubMed ID: 12195565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens (Sabal fructus)].
    Schilcher H
    Wien Med Wochenschr; 1999; 149(8-10):236-40. PubMed ID: 10483690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a multicenter trial of serenoa repens extract (permixon) in patients with chronic abacterial prostatitis].
    Lopatkin NA; Apolikhin OI; Sivkov AV; Aliaev IuG; Komiakov BK; Zhuravlev VN; Oshchepkov VN; Vinarov AZ; Bazhenov IV; Medvedev AA; Spivak LG; Eliseenko AG
    Urologiia; 2007; (5):3-7. PubMed ID: 18257155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saw palmetto extracts for benign prostatic hyperplasia.
    Segars LW
    J Fam Pract; 1999 Feb; 48(2):88-9. PubMed ID: 10037530
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
    Zlotta AR; Teillac P; Raynaud JP; Schulman CC
    Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.